Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

International perspectives on newborn screening.

R J Pollitt1

  • 1Children's Hospital, Western Bank, Sheffield, S10 2TH, UK. Rodney.Pollitt@sch.nhs.uk

Journal of Inherited Metabolic Disease
|June 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Commentary: What degree of hyperphenylalaninaemia requires treatment?

Journal of inherited metabolic disease·2012
Same author

Newborn blood spot screening: new opportunities, old problems.

Journal of inherited metabolic disease·2009
Same author

Qualitative urinary organic acid analysis: methodological approaches and performance.

Journal of inherited metabolic disease·2008
Same author

Introducing new screens: why are we all doing different things?

Journal of inherited metabolic disease·2007
Same author

Population quantile-quantile plots for monitoring assay performance in newborn screening.

Journal of inherited metabolic disease·2007
Same author

Newborn screening for cystic fibrosis: science, legislation, and human values.

Journal of inherited metabolic disease·2004

Electrospray tandem mass spectrometry (MS-MS) enhances newborn screening, but national policies vary widely. Greater concordance is needed for effective implementation of broad-spectrum disease detection.

Area of Science:

  • Biochemistry
  • Medical Genetics
  • Public Health Policy

Background:

  • Electrospray tandem mass spectrometry (MS-MS) has significantly expanded the scope of newborn blood-spot screening.
  • The adoption and application of MS-MS technology for detecting various diseases differ across countries.

Purpose of the Study:

  • To examine and compare current national policies for MS-MS based newborn screening in the United Kingdom, Germany, and the United States.
  • To highlight the lack of concordance in policy and the challenges in applying established screening principles.

Main Methods:

  • Comparative analysis of national newborn screening policies and guidelines.
  • Review of current practices in the UK, Germany, and the US regarding MS-MS use for disease detection.

Related Experiment Videos

Main Results:

  • Significant policy divergence exists: UK primarily uses MS-MS for phenylketonuria, Germany has restricted its use, and the US proposes broad screening.
  • There is a lack of a universally accepted framework for applying screening principles (Wilson and Jungner, 1968) to decision-making.

Conclusions:

  • The current lack of policy concordance is concerning for the effective implementation of advanced newborn screening technologies.
  • Alternative approaches are necessary to address the heterogeneity of disorders and the diverse benefits of screening beyond reducing morbidity or mortality.